Partner with us.
BETTER TOGETHER
Feromics sits at the intersection of three large and growing markets: AI in drug discovery, immunotherapy development, and precision immunology.
Feromics delivers functional intelligence at every stage of drug development — from target validation and donor selection to patient stratification and companion diagnostic development. Powered by our platform, every partnership is built on the same foundation: verified functional biology that produces better models, better predictions, and better medicine.
Partners can rely on data that is accurate, actionable, and reliable — delivered with the speed, cost efficiency, and single-cell precision only Feromics can provide.
Who we work with:
-
Pharmaceutical companies
-
Biotech organizations
-
AI and technology companies
-
Cell therapy manufacturers
-
Clinical developers
-
Academic medical centers and research institution
For Pharma partners, our platform creates several applications:
● Improved biomarker discovery
● Patient stratification
● Engager optimization
● Mechanistic understanding of disease relapse or treatment resistance
For Pharma partners, our platform creates several applications:
FUNDING: SUPPORTING OUR RESEARCH
The science is published. The technology is patented. The platform is government-validated.
-
Private Investment
-
ARPA-H
-
Awarded up to $4M 3-year contract from the Advanced Research Projects Agency for Health (ARPA-H) to develop a precision medicine technology to improve patient treatment selection in cancer immunotherapy.
-